Teva Pharmaceutical Industries Ltd Adr (TEVA)

01:52 AM

Teva Signals Confidence With $700 Million Pipeline Push, Buyback Plan - Benzinga

01:52 AM

12:42 PM

Teva Enjoys Strong Start to 2026 Thanks to Strong Momentum in Branded Portfolio - Morningstar

12:42 PM

Apr 27, 2026

Intel Upgraded, Toyota Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Apr 27, 2026

Apr 23, 2026

Dermatomycoses Market Report 2025-2035, Profiles of Prominent Players - GlobeNewswire Inc.

Apr 23, 2026

Apr 22, 2026

Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge? - Sahm

Apr 22, 2026

Apr 19, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch - Sahm

Apr 19, 2026

Apr 18, 2026

Teva- Pharmaceutical Industries Ltd.ADR (TEVA) News, Articles, Events & Latest Updates - Stocktwits

Apr 18, 2026

Apr 16, 2026

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners - Sahm

Apr 16, 2026

Apr 14, 2026

Teva Pharmaceutical (ADR) stock (US88162G1031): Why generic drug execution is suddenly worth a close - AD HOC NEWS

Apr 14, 2026

Apr 14, 2026

Does Biosimilar Wins in Osteoporosis and Allergy Care Change The Bull Case For Teva (TEVA)? - Sahm

Apr 14, 2026

Apr 12, 2026

A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Biosimilar Regulatory Milestones - Sahm

Apr 12, 2026

Apr 07, 2026

Target Upgraded, Robinhood Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Apr 07, 2026

Apr 05, 2026

How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones - Sahm

Apr 05, 2026

Apr 03, 2026

Assessing Teva Pharmaceutical Industries (TEVA) Valuation After New Biosimilar Approvals And Pipeline Progress - Sahm

Apr 03, 2026

Apr 02, 2026

Missile Strike Tests Teva Supply Resilience And Biosimilar Growth Plans - Sahm

Apr 02, 2026

Apr 01, 2026

Price to sales ratio of Teva Pharmaceutical Industries Limited Sponsored ADR – BSESOF:TEV - TradingView

Apr 01, 2026

Mar 30, 2026

Teva’s New Biosimilars Test Growth Plan And Earnings Reshaping Potential - Sahm

Mar 30, 2026

Mar 27, 2026

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

Mar 27, 2026

Mar 25, 2026

How Investors May Respond To Teva (TEVA) Advancing TEV ‘325 In Biologics For Inflammatory Diseases - Sahm

Mar 25, 2026

Mar 24, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Weakness - Sahm

Mar 24, 2026

Mar 20, 2026

TEVA Stock Price, Quote & Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Mar 20, 2026

Mar 19, 2026

Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LS:883035 - TradingView

Mar 19, 2026

Mar 19, 2026

Teva Releases Q1 2026 Aide Memoire - Sahm

Mar 19, 2026

Mar 18, 2026

Will Teva’s (TEVA) Olanzapine LAI Milestone and Legal Win Change Its Innovation-Led Narrative? - Sahm

Mar 18, 2026

Mar 17, 2026

Tesla Upgraded, Super Micro Computer Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2026

Mar 11, 2026

How Teva’s Blackstone-Backed ‘Pivot to Growth’ Strategy Could Reshape Teva Pharmaceutical Industries (TEVA) Investors - Sahm

Mar 11, 2026

Mar 10, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Pivot To Growth Update At Leerink Conference - Sahm

Mar 10, 2026

Mar 06, 2026

Teva Blackstone Duvakitug Deal Tests Growth Story And Concentration Risk - Sahm

Mar 06, 2026

Mar 03, 2026

Teva Drug Updates Support Branded Growth Story And Valuation Upside Potential - Sahm

Mar 03, 2026

Mar 02, 2026

What's Driving the Market Sentiment Around Teva Pharmaceutical Industries Ltd? - Sahm

Mar 02, 2026

Mar 01, 2026

Duvakitug IBD Data and TEV-749 Filing Might Change The Case For Investing In Teva (TEVA) - Sahm

Mar 01, 2026

Feb 28, 2026

Teva to Present at the Upcoming Investor Conferences in March - Sahm

Feb 28, 2026

Feb 27, 2026

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? - Finviz

Feb 27, 2026

Feb 26, 2026

Where is Teva Pharmaceutical Industries Limited (TEVA) Headed? - Finviz

Feb 26, 2026

Feb 25, 2026

Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz

Feb 25, 2026

Feb 23, 2026

FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application - Sahm

Feb 23, 2026

Feb 22, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Its Strong Recent Share Price Momentum - Sahm

Feb 22, 2026

Feb 20, 2026

Truist Boosts Teva (TEVA) Stock Target Amid Pipeline Growth Opportunities - Finviz

Feb 20, 2026

Feb 19, 2026

Corcept Therapeutics Stock Plunges As Court Clears Teva Generic - Sahm

Feb 19, 2026

Feb 18, 2026

Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026 - Finviz

Feb 18, 2026

Feb 18, 2026

Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Trades & News - GuruFocus

Feb 18, 2026

Feb 18, 2026

Teva’s Duvakitug Data Puts Ulcerative Colitis And Crohn’s Bet In Focus - Sahm

Feb 18, 2026

Feb 17, 2026

Should You Invest in Teva Pharmaceutical (TEVA), Here's What the Street Has to Say - Finviz

Feb 17, 2026